These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5952329)

  • 1. Effect of tranylcypromine upon 5-hydroxytryptaminergic neurons of rat brain stem.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1966; 14(4):365-70. PubMed ID: 5952329
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of monoamine oxidase inhibitors on the concentrations of dopamine and serotonin in the striatum of the cat with and without unilateral brainstem lesions.
    Singh P; Poirier LJ; Boucher R
    Can J Physiol Pharmacol; 1967 Sep; 45(5):897-904. PubMed ID: 6049616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of tranylcypromine on glycogenolysis in the rat brain].
    Rinaudo MT; Curto M; Bruno R; Torre E; Bogetto F; Torre M
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):148-52. PubMed ID: 17955640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of drugs on the firing of serotonin-containing neurons in brain.
    Aghajanian GK
    Fed Proc; 1972; 31(1):91-6. PubMed ID: 4333252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical implications of monoamine oxidase inhibition.
    Pare CM
    Adv Biochem Psychopharmacol; 1972; 5():441-4. PubMed ID: 5054212
    [No Abstract]   [Full Text] [Related]  

  • 8. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of certain psychopharmaca on intraneuronal levels of 5-HT and catecholamines in the specific monoamine neurons of the rat brain.
    Bartonicék V; Dahlström A; Fuxe K
    Experientia; 1964 Dec; 20(12):690-1. PubMed ID: 5858602
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of monoamine oxidase inhibitors on the tryptamine content of the rat brain and on "tryptamine convulsions"].
    Popov N; Lietz W; Matthies H
    Acta Biol Med Ger; 1967; 18(2):233-44. PubMed ID: 5586804
    [No Abstract]   [Full Text] [Related]  

  • 15. Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: an in vitro electrophysiological study.
    Mercuri NB; Federici M; Marinelli S; Bernardi G
    Synapse; 2000 Sep; 37(3):216-21. PubMed ID: 10881043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranylcypromine: new perspectives on an "old" drug.
    Frieling H; Bleich S
    Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):268-73. PubMed ID: 16927039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugar derivatives of indolamines, part II: difference in the oxidation of serotonin and its desoxyfructose derivative by rat brain monoamine oxidase.
    Bhargava KP; Gujrati VR; Ali B; Mester M; Mester L
    Thromb Res; 1978 May; 12(5):791-5. PubMed ID: 675588
    [No Abstract]   [Full Text] [Related]  

  • 18. A fluorescence and electron microscopic study on central monoamine nerve cells.
    Fuxe K; Hökfelt T; Nilsson O; Reinius S
    Anat Rec; 1966 May; 155(1):33-40. PubMed ID: 5961819
    [No Abstract]   [Full Text] [Related]  

  • 19. Time studies on the effects of tranylcypromine plus tryptophan on formation of tryptamine and 5-hydroxytryptamine in rat brain.
    Hay JL; McKim HR; Baker GB; Dewhurst WG
    Proc West Pharmacol Soc; 1982; 25():133-5. PubMed ID: 7122487
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.